PT
EW icon

Plimoth Trust’s Edwards Lifesciences EW Stock Holding History

Plimoth Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+2,278
New +$191K 0.04% 172
2026
Q1 		– Sell
-2,977
Closed -$254K – 175
2025
Q4 		$254K Sell
2,977
-86
-3% -$7.06K 0.06% 163
2025
Q3 		$238K Sell
3,063
-30
-1% -$2.34K 0.05% 163
2025
Q2 		$242K Buy
+3,093
New +$231K 0.06% 159
2025
Q1 		– Sell
-2,763
Closed -$205K – 162
2024
Q4 		$205K Buy
+2,763
New +$193K 0.05% 157
2024
Q3 		– Sell
-3,805
Closed -$351K – 160
2024
Q2 		$351K Sell
3,805
-29
-0.8% -$2.57K 0.09% 134
2024
Q1 		$366K Buy
3,834
+195
+5% +$16.4K 0.1% 134
2023
Q4 		$277K Sell
3,639
-220
-6% -$15.3K 0.08% 145
2023
Q3 		$267K Sell
3,859
-189
-5% -$15.2K 0.08% 144
2023
Q2 		$382K Sell
4,048
-25
-0.6% -$2.17K 0.11% 131
2023
Q1 		$337K Sell
4,073
-160
-4% -$12.6K 0.1% 141
2022
Q4 		$316K Buy
+4,233
New +$326K 0.1% 142

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Plimoth Trust's EW Position: Q2 2026 in Review

Plimoth Trust opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,278 shares worth $206K. The stake represents 0.04% of the portfolio and ranks #172 among its holdings. This is a return to the name: Plimoth Trust previously reported a position in EW as recently as Q4 2025.

Plimoth Trust first reported a position in EW in Q4 2022 and has held it in 12 quarters since. The position peaked at $382K in Q2 2023. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Plimoth Trust held 2,278 shares of Edwards Lifesciences worth $206K as of Q2 2026.
  • Edwards Lifesciences was a new Plimoth Trust position in Q2 2026.
  • Edwards Lifesciences made up 0.04% of Plimoth Trust's portfolio in Q2 2026, its #172 holding.
  • Plimoth Trust first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 12 quarters since.
  • Plimoth Trust's Edwards Lifesciences position peaked at $382K in Q2 2023.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Plimoth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.